» Articles » PMID: 38893090

Quantitative Bone SPECT/CT of Central Cartilaginous Bone Tumors: Relationship Between SUVmax and Radiodensity in Hounsfield Unit

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2024 Jun 19
PMID 38893090
Authors
Affiliations
Soon will be listed here.
Abstract

(1) Background: it is challenging to determine the accurate grades of cartilaginous bone tumors. Using bone single photon emission computed tomography (SPECT)/computed tomography (CT), maximum standardized uptake value (SUVmax) was found to be significantly associated with different grades of cartilaginous bone tumor. The inquiry focused on the effect of the tumor matrix on SUVmax. (2) Methods: a total of 65 patients from 2017 to 2022 with central cartilaginous bone tumors, including enchondromas and low-to-intermediate grade chondrosarcomas, who had undergone bone SPECT/CT were retrospectively enrolled. The SUVmax was recorded and any aggressive CT findings of cartilaginous bone tumor and Hounsfield units (HU) of the chondroid matrix as mean, minimum, maximum, and standard deviation (SD) were reviewed on CT scans. Pearson's correlation analysis was performed to determine the relationship between CT features and SUVmax. Subgroup analysis was also performed between the benign group (enchondroma) and the malignant group (grade 1 and 2 chondrosarcoma) for comparison of HU values and SUVmax. (3) Results: a significant negative correlation between SUVmax and HU measurements, including HUmax, HUmean, and HU, was found. The subgroup analysis showed significantly higher SUVmax in the malignant group, with more frequent CT aggressive features, and significantly lower HU in the malignant group than in the benign group. (4) Conclusions: it was observed that higher SUVmax and lower HU were associated with a higher probability of having a low-to-intermediate chondrosarcoma with aggressive features and a less calcified tumor matrix.

References
1.
Ulano A, Bredella M, Burke P, Chebib I, Simeone F, Huang A . Distinguishing Untreated Osteoblastic Metastases From Enostoses Using CT Attenuation Measurements. AJR Am J Roentgenol. 2016; 207(2):362-8. DOI: 10.2214/AJR.15.15559. View

2.
Kim J, Lee S . Classification of Chondrosarcoma: From Characteristic to Challenging Imaging Findings. Cancers (Basel). 2023; 15(6). PMC: 10046282. DOI: 10.3390/cancers15061703. View

3.
Murphey M, Flemming D, Boyea S, Bojescul J, Sweet D, Temple H . Enchondroma versus chondrosarcoma in the appendicular skeleton: differentiating features. Radiographics. 1998; 18(5):1213-37; quiz 1244-5. DOI: 10.1148/radiographics.18.5.9747616. View

4.
Lee S, Yoon M . Assessment of central cartilaginous tumor of the appendicular bone: inter-observer and intermodality agreement and comparison of diagnostic performance of CT and MRI. Acta Radiol. 2021; 63(3):376-386. DOI: 10.1177/0284185121996268. View

5.
Dierselhuis E, Gerbers J, Ploegmakers J, Stevens M, Suurmeijer A, Jutte P . Local Treatment with Adjuvant Therapy for Central Atypical Cartilaginous Tumors in the Long Bones: Analysis of Outcome and Complications in One Hundred and Eight Patients with a Minimum Follow-up of Two Years. J Bone Joint Surg Am. 2016; 98(4):303-13. DOI: 10.2106/JBJS.O.00472. View